Bioscience

UA spin-off launches clinical trial

May 16, 2013

By Flinn Foundation

 

From: UA News

Tucson-based Cancer Prevention Pharmaceuticals, Inc. has helped launch a Phase III clinical trial to test the efficacy of a combination drug that has shown promise of preventing colon cancer. The company was founded by a University of Arizona professor emeritus and former UA researcher. The trial is funded by the National Cancer Institute.

Read More: